Free. Unsubscribe any time.
PUMA BIOTECHNOLOGY, INC. (PBYI)
PUMA BIOTECHNOLOGY, INC. filed 27 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 33 transactions and 508,755 shares. None carries the SEC's AFF10B5ONE flag; all 27 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-16, came on the same day as the one before it (2026-09-16) and reports 1 transaction against 3 in the filing before it.
- The sales it reports total 5,000 shares, 57,150 fewer than the 62,150 in the filing before it.
- Its 27 plan statements rank 224th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 27 filings on file run from 2025-01-03 to 2026-09-16, and state no plan adoption date.
Trades in PUMA BIOTECHNOLOGY, INC. 33
- AUERBACH ALAN H — 2025-01-02 · S · 33,841 shares
- HUNT DOUGLAS M — 2025-01-02 · S · 8,633 shares
- Ludwig Jeffrey Jerome — 2025-01-02 · S · 9,437 shares
- NOUGUES MAXIMO F — 2025-01-02 · S · 10,227 shares
- Cesano Alessandra — 2025-06-13 · S · 12,150 shares
- Dorval Allison — 2025-06-13 · S · 11,610 shares
- MOYES JAY M — 2025-06-13 · S · 22,000 shares
- Senderowicz Adrian — 2025-06-13 · S · 27,000 shares
- Stuglik Brian M — 2025-06-13 · S · 8,100 shares
- WILSON TROY EDWARD — 2025-06-13 · S · 10,800 shares
- AUERBACH ALAN H — 2025-07-08 · S · 25,592 shares
- HUNT DOUGLAS M — 2025-07-08 · S · 4,374 shares
Adoption dates in PUMA BIOTECHNOLOGY, INC. 0
Results prints in PUMA BIOTECHNOLOGY, INC. 7
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
Trades before a print in PUMA BIOTECHNOLOGY, INC. 0
- 20 days before the 2025-08-07 print — 2025-07-18 · S · Cesano Alessandra · 27,000 shares
- 29 days before the 2025-08-07 print — 2025-07-09 · S · AUERBACH ALAN H · 21,580 shares
- 29 days before the 2025-08-07 print — 2025-07-09 · S · HUNT DOUGLAS M · 3,443 shares
- 29 days before the 2025-08-07 print — 2025-07-09 · S · NOUGUES MAXIMO F · 3,935 shares
- 30 days before the 2025-08-07 print — 2025-07-08 · S · AUERBACH ALAN H · 25,592 shares
- 30 days before the 2025-08-07 print — 2025-07-08 · S · HUNT DOUGLAS M · 4,374 shares
- 30 days before the 2025-08-07 print — 2025-07-08 · S · NOUGUES MAXIMO F · 5,587 shares
- 31 days before the 2026-08-06 print — 2026-07-06 · S · AUERBACH ALAN H · 44,058 shares
- 31 days before the 2026-08-06 print — 2026-07-06 · S · HUNT DOUGLAS M · 8,460 shares
- 31 days before the 2026-08-06 print — 2026-07-06 · S · NOUGUES MAXIMO F · 9,386 shares
- 50 days before the 2026-02-26 print — 2026-01-07 · S · AUERBACH ALAN H · 18,012 shares
- 50 days before the 2026-02-26 print — 2026-01-07 · S · HUNT DOUGLAS M · 5,014 shares
Interval to PUMA BIOTECHNOLOGY, INC.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 20shortest, days
- 2no later print
Reported results dates on file
- 2025-02-27
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-02-26
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.